Status:
TERMINATED
Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer
Lead Sponsor:
West Virginia University
Collaborating Sponsors:
American Cancer Society, Inc.
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will help researchers learn about the best dose of radiation to be used when treating large early stage non-small cell lung cancer (NSCLC) with a treatment called stereotactic ablative radi...
Detailed Description
Treatment Plan: 7.5 Gy x 10 daily fractions delivered with volumetric modulated arc therapy (VMAT) or regular intensity-modulated radiation therapy (IMRT). * Optional schedule of 12 Gy x 5 daily fra...
Eligibility Criteria
Inclusion
- Non-Small Cell Lung Cancer
- T2N0M0 or T3(PL3)N0M0 or Locally recurrent ≤ 7 cm
- Surgically inoperable
- ECOG Performance 0-2
Exclusion
- Pacemaker on the same side of the tumor
- Pregnant
- Infection that requires IV antibiotics
- Concomitant or adjuvant anti-neoplastic chemotherapy
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2017
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT02262000
Start Date
September 1 2013
End Date
July 10 2017
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West Virginia University Hospitals Mary Babb Randolph Cancer Center
Morgantown, West Virginia, United States, 26506